Willem Lybaert

2PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 30, 2023
NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer.

Katleen Janssens, Greetje Vanhoutte, Willem Lybaert

|Mar 23, 2021
Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key.

Michael Saerens, Vibeke Kruse, Willem Lybaert

Pageof 1